证券代码：300897 证券简称：山科智能 杭州山科智能科技股份有限公司 投资者关系活动记录表 编号：2025-001 | 投资者关系 | 特定对象调研 分析师会议 | | --- | --- | | 活动类别 | □媒体采访  业绩说明会 | | | □新闻发布会 路演活动 | | | 现场参观 其他 | | 参与单位名称 | 线上参与山科智能 2024 年网上业绩说明会的投资者 | | 及人员姓名 | | | 时 间 | 2025 年 5 月 6 日（星期二）15:00-17:00 | | 地 点 | 深圳证券交易所"互动易"平台（http://irm.cninfo.com.cn）"云访 | | | 谈"栏目 | | 上市公司接待 | 1、董事长：钱炳炯先生； | | | 2、董事兼董事会秘书：王雪洲先生； | | 人员姓名 | 3、财务总监：周琴女士； | | | 4、独立董事：丁茂国先生。 | | | 交流内容如下： | | | 1、公司之后的盈利有什么增长点？ | | 投资者关系活 | 答：您好！目前国家相关政策积极支持智慧水利和智慧直饮水发展， | | | 智慧水利和智慧直饮水的市场前 ...

Financial Performance - The company has maintained a cash dividend policy for six consecutive years, with a payout ratio exceeding 30% of net profit, totaling CNY 431 million [2] - In Q1 2025, the company reported revenue of CNY 53.58 million, a year-on-year decrease of 1.57%, with the mobile terminal business contributing 27.81% and the new energy business contributing 43.27% to total revenue [30] - The net profit attributable to shareholders was CNY 44.25 million, reflecting a year-on-year increase of 31.81% [30] Business Strategy - The company follows a "3+N" business strategy focusing on mobile terminals, new energy, and precision components, while also serving as a core supplier in various sectors including photovoltaic, automotive, medical, and semiconductor industries [11] - The company is actively exploring opportunities in emerging markets and enhancing its technological capabilities in semiconductor packaging, smart logistics, and medical device manufacturing [3][4] Market Position and Challenges - The company faces challenges in market recognition despite its strong fundamentals, with stock prices not reflecting true value [2] - The impact of trade tariffs on operations is considered limited and manageable, with ongoing efforts to strengthen overseas business capabilities [9] Product Development and Innovation - The company is engaged in the development of intelligent logistics equipment and has been collaborating with leading clients in drone delivery and automated storage solutions since 2018 [4] - Continuous investment in R&D for high-speed battery assembly lines and advanced technologies in the new energy sector is a priority [18] Customer Relations and Order Stability - The company maintains stable relationships with key clients, ensuring a robust order book and ongoing business development efforts [5][12] - The company emphasizes strict contract execution and proactive management of accounts receivable to mitigate financial risks [26] Future Outlook - The company aims to enhance its operational efficiency and market competitiveness by optimizing its business model and expanding its overseas presence [17] - The focus will remain on high-margin products and strengthening capabilities in smart manufacturing and automation solutions [18]

Group 1: Company Development Plans - The company aims to focus on breakthroughs in solid-state battery technology, enhancing production efficiency and performance to meet market demands for high energy density and safety [3] - Plans include deepening the layout of negative electrode materials and scaling up the application of silicon-carbon materials to enhance competitiveness in key lithium battery materials [3] - Development of lithium resources and rare metals through low-temperature sulfuric acid production lines to strengthen upstream resource security [3] - Establishing a circular economy system by improving battery recycling processes and promoting resource recycling [3] - The company will leverage technological innovation and equipment upgrades to become a core competitive player in the new energy sector [3] Group 2: Financial Challenges and Strategies - The company faces significant challenges with declining revenue and net profit, high debt ratios, and cash flow pressures due to long accounts receivable periods [4][7] - Measures to address these challenges include enhancing risk awareness regarding bad debts, optimizing product structures, and increasing R&D investments in subsidiaries [4] - The first quarter inventory increased by 33% year-on-year, primarily due to increased orders for lithium battery equipment [5] - The company reported a 33% decline in total revenue for 2024, with lithium battery equipment revenue dropping from 55% to 47% [8] Group 3: Market Expansion and Opportunities - The company plans to expand into overseas markets by leveraging partnerships with domestic battery manufacturers and participating in international industry exhibitions [6] - Future growth points include focusing on solid-state battery technology, negative electrode material development, and the construction of a circular economy [6][9] - The company is addressing the challenges of high customer concentration and industry growth slowdown by enhancing technology and product offerings [9] Group 4: R&D and Innovation - In 2024, the company invested approximately 89.29 million CNY in R&D, accounting for 5.92% of total revenue, which has facilitated breakthroughs in various technology fields [12] - The company has developed a series of intelligent manufacturing equipment for lithium (sodium) batteries, enhancing production efficiency [13] - The low-temperature sulfuric acid method significantly reduces waste generation compared to traditional methods, promoting sustainable practices [8] Group 5: Future Industry Outlook - Despite challenges in 2024, the lithium battery equipment industry is expected to see positive trends driven by the rapid development of the new energy vehicle market [11] - Emerging applications in semi-solid and solid-state batteries will create new growth opportunities [11] - The company’s low-temperature sulfuric acid lithium extraction technology is internationally leading and could change industry standards if widely adopted [11]

Group 1: Company Overview and Core Business Areas - The company focuses on two core areas: brain-machine interfaces and vehicle-road-cloud technology, aiming for product deployment in the short term [2]. - The vehicle-road-cloud technology will provide a comprehensive solution from road perception to cloud data processing, enhancing smart traffic scenarios [2]. - The company is accelerating its layout in smart parking operations and leasing businesses, while the brain-machine products have significant potential in medical, educational, and elderly care applications [2]. Group 2: Market Growth and Industry Challenges - The global brain-machine interface market is projected to grow at a compound annual growth rate (CAGR) of 25.22%, reaching $7.63 billion by 2029, with China's market expected to exceed 10 billion yuan by 2028 [3]. - The main challenges in the brain-machine industry include signal recognition accuracy and speed, as well as the complexities of neural signal transmission [4]. Group 3: Technological Advantages and Differentiation - The company utilizes a multi-modal data fusion technology combining EEG, EOG, and EMG to overcome the limitations of traditional single-modal devices [4]. - The company’s non-invasive brain-machine interface technology differs from competitors like Neuralink, focusing on accessibility and preventive applications in education and elderly care [5]. Group 4: Historical Development and Financial Performance - The company has evolved through four stages since its founding in 1998, from developing fingerprint technology to becoming a global leader in multi-modal biometric devices [6][7]. - Recent revenue growth has been stable, influenced by macroeconomic conditions domestically, while overseas business continues to grow [7]. Group 5: Strategic Responses to Market Conditions - To maintain gross margins, the company has adjusted its product structure, reducing low-margin and loss-making products [7]. - The company has proactively established a factory in Thailand to mitigate the impact of tariffs on its U.S. operations, with minimal short-term effects anticipated [7].

Financial Performance - In 2024, the company achieved a revenue of 6.744 billion CNY, representing a year-on-year growth of 18.25%, marking the fourth consecutive year of double-digit growth [1] - The net profit attributable to shareholders was 359 million CNY, with a net profit margin of 5.34% [1] - Revenue from the automotive parts segment was 5.002 billion CNY, accounting for 74.18% of total revenue, with a year-on-year increase of 12.86% [1] - Revenue from energy storage equipment reached 1.217 billion CNY, making up 18.04% of total revenue, with a significant year-on-year growth of 123% [1] - The company reported a revenue of 1.636 billion CNY in Q1 2025, with a net profit of 82.79 million CNY and a net profit margin of 5.06% [1] Strategic Development - The company aims to accelerate global expansion, targeting increased overseas revenue share [2] - Plans are in place to expedite the construction of a factory in Thailand to cover the Southeast Asian market for new energy vehicles and energy storage [2] - The company intends to establish a factory in Europe or North Africa to serve the European new energy vehicle market, with initial projects already received from international automakers [2] - The company is focusing on three key areas for high-quality development: smart robotics, low-altitude economy, and liquid cooling solutions [2] Product and Market Outlook - The company anticipates further revenue growth in automotive seating and energy storage products [4] - There is an ongoing effort to expand the customer base and increase market penetration, particularly among small and medium-sized clients [5] - The company is addressing potential revenue declines by actively seeking high-quality domestic and international business opportunities and optimizing product structure [5] Customer Base and Partnerships - Major automotive clients include mainstream manufacturers such as GAC Group, Geely, BYD, and NIO [3] - The company has established strategic partnerships in the low-altitude economy sector and is developing solutions for humanoid robots [6][7] - The company is in communication with various clients in the robotics sector, focusing on tailored solutions [9] Technological Innovations - The company is advancing its liquid cooling technology, which significantly enhances safety in electric vehicles [12] - The new cooling technology is expected to be applied across various sectors, including new energy vehicles, energy storage, and computing servers [12]

Group 1: Company Performance and Financials - The company has signed a contract for a certain optical system with a value of 71 million RMB, which is expected to enhance its equipment business development space [3] - The company aims to achieve a sales revenue target of 500 million RMB for the year, supported by identified projects and sales target agreements [5] - As of the end of 2024, the company has a cash balance of 108 million RMB, with most bank loans being medium to long-term credit loans [19] - The company has accumulated a credit loss provision of 305.017 million RMB, which will be adjusted upon recovery of receivables [8] Group 2: Research and Development - The company invests heavily in R&D, with R&D personnel salaries and benefits accounting for 65.67% of R&D expenses [11] - The new optical base is expected to have an annual production capacity of 200 complex optical systems and 1,800 optical products, aiming for over 3 billion RMB in revenue [12][25] - The company has developed several optical turret products for various platforms, including drones and ships, to meet diverse operational needs [10][37] Group 3: Market and Product Development - The company has established partnerships with several domestic enterprises in the drone and unmanned boat sectors, showing positive progress [26] - The company is focusing on expanding its market presence in infrared products for personal consumption and power monitoring applications [52] - The company is actively participating in equipment research project bidding and has achieved breakthroughs in multiple fields [9] Group 4: Challenges and Strategies - The company plans to reverse its losses through enhanced marketing, increased receivables collection, and strict cost control [48] - The company has faced challenges with delayed orders leading to high inventory turnover days [35] - The company is committed to maintaining transparency and compliance with legal regulations, denying any allegations of financial misconduct [60]

Strategic Development - The company focuses on four major strategic directions for growth: technology innovation and R&D investment, capacity layout optimization and supply chain management, market expansion and customer structure optimization, and actively seeking parallel development fields [1][2][4]. - The company plans to enhance R&D investment to improve the performance of core products, such as polycarboxylate superplasticizers, and provide customized solutions for customers [1][2]. Production and Capacity - The company has established over 20 production bases nationwide, optimizing regional capacity layout and aiming to reduce costs through centralized procurement and supply chain digitization [2][4]. - The annual production capacity for the epoxy ethane and propylene derivatives project is 320,000 tons, currently in trial production [8][12][15]. Sales and Financial Performance - In 2024, the company sold 620,000 tons of concrete additives, maintaining a similar volume to 2023, while the first quarter of 2025 saw a 15% increase in sales compared to the same period in 2024 [10][16]. - The revenue from concrete additives decreased by 11.06% in 2024 due to lower material and sales prices, with a gross margin decline of 3.70% [10][16]. Market Position and Competitiveness - The company aims to strengthen its market position in the concrete additives sector by increasing customer numbers and stabilizing shipment volumes [10][16]. - The company is exploring new high-value areas to enhance revenue and profitability, leveraging its existing product lines and market conditions [11][12]. Future Outlook - The company anticipates that the new Huizhou project will contribute significantly to revenue growth, with estimates suggesting an increase of 400 to 600 million [12][16]. - The company is committed to maintaining a stable dividend strategy while focusing on cost reduction and efficiency improvements to enhance overall business performance [10][14].

Group 1: Financial Performance - In 2024, the company achieved revenue of CNY 2.549 billion, with a net profit of CNY 127 million, representing a decline of 11.98% and 59.44% year-on-year respectively [5] - In Q1 2025, the company reported revenue of CNY 510 million and a net profit of CNY 24 million, down 17.22% and 80.09% year-on-year [5] - The revenue from agency products in 2024 was CNY 612 million, while revenue from self-developed products was CNY 1.913 billion, with a growth of 1.75% in self-developed product sales [5] Group 2: Product Performance - In 2024, self-developed immunological reagents generated CNY 1.029 billion in revenue, an increase of 8.04% year-on-year; biochemical reagents generated CNY 499 million, a decrease of 12.53%; and clinical testing reagents generated CNY 214 million, an increase of 21.70% [5] - In Q1 2025, self-developed product sales revenue was CNY 407 million, down 3.23% year-on-year, with immunological reagents at CNY 210 million (down 4.20%), biochemical reagents at CNY 95 million (down 26%), and clinical testing reagents at CNY 49 million (stable) [6] Group 3: Profitability and Cost Management - The overall gross margin for 2024 was approximately 55%, with a decline of about 1 percentage point in Q1 2025 compared to Q1 2024 [7] - The gross margin for self-developed products decreased by 4.76 percentage points, while the average gross margin for self-developed reagents remained stable at around 80% [9] - In 2024, operational expenses were effectively controlled, with sales expenses down about 1%, management expenses down about 10%, and financial expenses down about 30% [10] Group 4: Business Strategy and Market Trends - The company is focusing on the separation of agency business and enhancing self-developed products, with a strategic shift towards automated laboratory solutions [5] - The impact of national policies such as medical insurance reform and centralized procurement is expected to gradually manifest, with an estimated 20%-30% impact on overall testing volumes in the terminal market [14] - The company plans to limit the proportion of agency products to below 10% in the future, as the revenue from agency products has significantly decreased [20] Group 5: International Business and Future Outlook - In 2024, overseas sales revenue reached CNY 160 million, a year-on-year increase of nearly 60%, with Q1 2025 overseas sales revenue close to CNY 50 million, up 90% [15] - The company is optimistic about future overseas sales and plans to establish a new overseas sales subsidiary in 2025 [15] - The company anticipates that the next two to three years will be critical for industry development, with a focus on enhancing market share in both domestic and international markets [21]

Group 1: Company Performance Overview - In 2024, the company achieved an operating income of approximately 119,400.24 million yuan, a year-on-year decrease of about 7.71% [2] - The net profit attributable to shareholders was approximately 4,138.51 million yuan, down about 49.00% year-on-year [2] - The net profit after deducting non-recurring gains and losses was approximately -165.63 million yuan, an increase of about 91.59% year-on-year [2] - In Q1 2025, the company reported an operating income of approximately 25,069.71 million yuan, a year-on-year increase of about 6.08% [3] - The net profit attributable to shareholders in Q1 2025 was approximately 1,118.20 million yuan, a year-on-year increase of about 128.26% [3] Group 2: Overseas Market Expansion - The company has established offices in regions such as the Belt and Road countries, Southeast Asia, and the CIS to enhance overseas market penetration [3] - In 2024, revenue from overseas markets reached approximately 43,593.01 million yuan, a year-on-year increase of 21.29% [3] - The company’s overseas business gross margin is higher than domestic due to the increasing proportion of microwave antennas in overseas operations [3] Group 3: Satellite Communication Business - In 2024, the satellite communication business generated revenue of approximately 4,280.02 million yuan, accounting for 3.58% of total operating income [4] - The company plans to increase R&D investment in satellite communication to enhance product performance and market share [5] - The company has successfully delivered products in the ground station terminal market and is focusing on expanding its presence in satellite communication [5] Group 4: 5G-A Integrated Antenna Business - The company has made significant progress in the 5G-A integrated antenna business, achieving small batch deliveries [5] - The business is expected to grow further with the implementation of low-altitude economy policies and related regulations [5]

Company Overview - Established in 2001, the company launched its first multi-channel sleep monitor in 2003 and the first CPAP sleep machine in 2007. It received CE certification in 2008 and FDA certification in 2012. The company was successfully listed on the Shenzhen Stock Exchange's Growth Enterprise Market on November 1, 2022 [1][2]. - The company specializes in providing comprehensive treatment solutions for OSA and COPD patients, covering the entire cycle from diagnosis to treatment and chronic disease management. It is a leading domestic manufacturer of non-invasive ventilators and masks, with products sold in over 100 countries [1][2]. Research and Development - As of December 31, 2024, the company holds 633 valid patents in China, including 107 invention patents, 390 utility model patents, and 136 design patents. It also has 202 valid overseas patents [2]. Financial Performance - In Q1 2025, the company reported overseas revenue of 170 million CNY, a year-on-year increase of 35.48%. Domestic revenue was 96 million CNY, with a quarter-on-quarter growth of 48.79% and a year-on-year growth of 43.03% [3]. - The gross margin for domestic operations was 51.51%, while for overseas operations it was 48.47%. Both margins showed an increase compared to the previous quarter, with the U.S. market gross margin rising by 4.56% [3]. Business Segments - Revenue from home ventilator therapy reached 176 million CNY in Q1 2025, reflecting a quarter-on-quarter increase of 15.71% and a year-on-year increase of 62.80%. Revenue from consumables was 81 million CNY, with a quarter-on-quarter growth of 3.21% and a year-on-year growth of 7.46% [3]. - The gross margin for home ventilator therapy was 43.20%, while for consumables it was 64.39%, indicating stable margins for both segments [3]. Production and Supply Chain - The company has established major production bases in Tianjin and Dongguan, achieving domestic substitution for core components, ensuring supply chain security and cost advantages [4]. Brand Strategy - The company is rebranding from "怡和嘉业" to "瑞迈特" to enhance brand recognition and reduce confusion among consumers and investors. The new brand aims to increase market penetration and influence [4]. Market Development - The cloud platform in the European market is nearly complete, with over 20 agents connected, laying the groundwork for future growth in the respiratory machine market [5]. - The recently launched P5 series ventilators are primarily targeted at domestic hospital channels, which have a relatively high gross margin [6]. Strategic Investments - The investment in Shenzhen Deda Xing Drive Technology Co., Ltd. aims to secure a stable supply of core components and extend the company's business upstream, aligning with its long-term strategic goals [6]. Technological Collaboration - The company is exploring opportunities for collaboration with Zhejiang Qiangnao Technology Co., Ltd. in the field of brain-computer interface technology, which could enhance sleep monitoring and intervention capabilities [7].